Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

2017

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

37

References

16

Citations